Article Details

Chance Pharmaceuticals Secures $30 Million Series C Funding to Advance Innovative Pipeline and

Retrieved on: 2021-10-11 00:00:00

Tags for this article:

Click the tags to see associated articles and topics

Chance Pharmaceuticals Secures $30 Million Series C Funding to Advance Innovative Pipeline and. View article details on hiswai:

Excerpt

About Lapam Capital Lapam Capital is a leading healthcare-focused venture capital firm with its headquarter in Beijing, China. It currently manages four ...

Article found on: www.kulr8.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up